Table 1 General characteristics of cases and controls
Variables | Level | Cases (n = 16) | Controls (n = 32) | P-value |
|---|---|---|---|---|
Study site | Kawaala HC | 2 (12.5) | 1 (3.1) | 0.122 |
Kisenyi HC | 9 (56.2) | 13 (40.6) | ||
Kisugu HC | 0 (0.0) | 1 (3.1) | ||
Kiswa HC | 1 (6.2) | 3 (9.4) | ||
Kitebi HC | 0 (0.0) | 10 (31.2) | ||
Komamboga HC | 4 (25.0) | 4 (12.5) | ||
Level of health facility | HC III | 7 (43.8) | 19 (59.4) | 0.473 |
HC IV | 9 (56.2) | 13 (40.6) | ||
Age group (years) | 15–24 | 7 (43.8) | 11 (34.4) | 0.212 |
25–34 | 4 (25.0) | 16 (50.0) | ||
35 and more | 5 (31.2) | 5 (15.6) | ||
Mean (SD) | 26.2 (15.7) | 27.8 (9.8) | 0.674 | |
Sex | Female | 11 (68.8) | 24 (75.0) | 0.909 |
Male | 5 (31.2) | 8 (25.0) | ||
Point of entry into HIV care | Others | 0 (0.0) | 3 (9.4) | 0.471 |
Outpatient department | 10 (62.5) | 15 (46.9) | ||
PMTCT clinic | 6 (37.5) | 13 (40.6) | ||
TB clinic | 0 (0.0) | 1 (3.1) | ||
Mid-upper arm circumference | Green (well-nourished) | 15 (93.8) | 32 (100.0) | 0.721 |
Yellow (moderately malnourished) | 1 (6.2) | 0 (0.0) | ||
Baseline CD4 (cells/ml) | 500 and more | 13 (81.2) | 27 (84.4) | 1.000 |
Less than 500 | 3 (18.8) | 5 (15.6) | ||
VL before IAC (copies/ml) | Less or equal to 10,000 | 8 (50.0) | 11 (34.4) | 0.465 |
More than 10,000 | 8 (50.0) | 21 (65.6) | ||
ART regimen | ABC-3TC-EFV | 3 (18.8) | 2 (6.2) | 0.058 |
ABC/3TC/DTG | 1 (6.2) | 0 (0.0) | ||
Other first-line regimens | 2 (12.5) | 0 (0.0) | ||
TDF-3TC-EFV | 0 (0.0) | 1 (3.1) | ||
TDF/3TC/DTG | 10 (62.5) | 29 (90.6) | ||
Baseline WHO clinical stages | I and II | 15 (93.8) | 31 (96.9) | 1.000 |
III and IV | 1 (6.2) | 1 (3.1) | ||
Frequency of IAC | 3 | 6 (37.5) | 26 (81.2) | 0.009 |
4 | 9 (56.2) | 5 (15.6) | ||
5 | 1 (6.2) | 1 (3.1) |